Patents by Inventor Marc TRITEL

Marc TRITEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND SEQUELAE THEREOF
    Publication number: 20230338432
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells for treating viral infections and sequelae thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: October 26, 2023
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob YANAY, Rachel OFIR, Marc TRITEL
  • THERAPEUTIC METHODS AND COMPOSITIONS
    Publication number: 20210338740
    Abstract: Disclosed herein are pharmaceutical compositions and methods comprising or utilizing placental adherent stromal cells. The pharmaceutical compositions may be indicated for ameliorating or treating various disorders, e.g., impaired glucose tolerance. Alternatively, the pharmaceutical composition may be indicated for ameliorating or treating systemic inflammation, e.g., in a subject with impaired glucose tolerance. The pharmaceutical compositions may further include pharmacologically acceptable excipients.
    Type: Application
    Filed: November 6, 2019
    Publication date: November 4, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Zami ABERMAN, Yaacob YANAY, Rachel OFIR, Marc TRITEL, Hoshea Yissachar ALLEN, Niva SHRAGA HELED
  • METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
    Publication number: 20210283189
    Abstract: Disclosed herein are methods and compositions comprising placental adherent stromal cells for treating viral infections and sequelae thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: September 16, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Yaacob Yanay, Rachel Ofir, Marc Tritel
  • THERAPEUTIC DOSAGE REGIMENS COMPRISING ADHERENT STROMAL CELLS
    Publication number: 20210228635
    Abstract: Disclosed herein are pharmaceutical compositions and therapeutic dosage regimens comprising or utilizing adherent stromal cells. The adherent stromal cells may be derived e.g. from placental tissue, from adipose tissue, or from bone marrow. The pharmaceutical compositions may be indicated for treating various disorders, e.g. ischemic disorders, hematopoietic disorders, and neurodegenerative disorders, inflammatory disorders, and neoplasms. The pharmaceutical compositions may further include pharmacologically acceptable excipients.
    Type: Application
    Filed: June 10, 2019
    Publication date: July 29, 2021
    Applicant: PLURISTEM LTD.
    Inventors: Zami ABERMAN, Yaacob YANAY, Rachel OFIR, Marc TRITEL